Michel Timperio

Michel Timperio is a declared insider of Acasti Pharma Inc., with filings sourced from SEDI. Activity is concentrated on a single trading day, 20 November 2017, with 3 filings.

On the market, this insider has only sold: 3 sales, €8,461 in total.

On 23 November 2017 came the latest disclosure, an open-market sale for €5,825 in Acasti Pharma Inc. The median gap between a trade and its publication by SEDI is 3 days. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.